EUVIMEDEUVIMED entdecken
Crossref

Polygonatum Odoratum (Mill.) Druce Alleviates Lipopolysaccharide‐Induced Inflammation and Improves the Ovarian Function in Polycystic Ovary Syndrome Rats

Biao Zheng, Xuan Che, Zhuo Chen, Di Cheng, Congbing Huang, Zhaoming Zeng, Zhongcheng Mo iD

American Journal of Reproductive Immunology · 2025

DOI: 10.1111/aji.70116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Biao Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health, Guilin Medical University, Guilin, Guangxi, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Polygonatum, Inflammation, Ovary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Foundation of Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health, Special Fund of the Central Government Guiding Local Scientific and Technological Development by Guangxi Science and Technology Department, Horizontal Cooperation project with Hunan Mingshun Pharmaceutical Co., Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Problem Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, oligoovulation or anovulation, and the morphology of polycystic ovaries. Polygonatum odoratum (Mill.) Druce (POD), a key component of the traditional Chinese herb Polygonatum odoratum, has uncertain effects on improving ovarian function and inflammation in patients with PCOS. Method of Study Network pharmacological analysis was conducted to explore the processes and signaling pathways of POD in the treatment of PCOS. Letrozole via gavage induced the PCOS model rats. Ovarian morphology and the ovarian body index were assessed, and the numbers of corpora lutea and cystic follicles were quantified after hematoxylin‒eosin staining. Testosterone and fasting blood glucose levels were measured, and glucose tolerance was evaluated. Additionally, IL‐1β and TNF‐αlevels in the ovaries were detected using immunohistochemistry and western blotting.

Results

Network pharmacology identified a total of 107 potential targets associated with POD and PCOS, suggested that POD could treat PCOS through mechanisms involving inflammation, the response to LPS, metabolic pathways. Experiments demonstrated that LPS reduced the number of corpora lutea and increased the number of cystic follicles while also impairing glucose regulation in PCOS rats. Moreover, LPS increased the expression levels of IL‐1β and TNF‐α. Treatment with POD mitigated these changes.

Conclusions

Our findings indicate that LPS exacerbates ovarian dysfunction and inflammation in PCOS rats, while POD effectively reverses these changes, suggesting a promising avenue for research into the therapeutic potential of traditional Chinese medicine in the treatment of PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromePolygonatumInflammationOvaryDrugs, Chinese HerbalPlant ExtractsAnimalsFemaleRatsRats, Sprague-DawleyLipopolysaccharidesDisease Models, AnimalTumor Necrosis Factor-alphaInterleukin-1betaHumansBlood Glucose

Stichwörter der Autor:innen

inflammationlipopolysaccharideovarian functionpolycystic ovary syndromepolygonatum odoratum (Mill.) Druce

Substanzen

LipopolysaccharidesDrugs, Chinese HerbalTumor Necrosis Factor-alphaInterleukin-1betaBlood GlucosePlant Extracts

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health, Guilin Medical University, Guilin, Guangxi, China.
  • Guangxi Province Postgraduate Co-Training Base for Cooperative Innovation in Basic Medicine (Guilin Medical University & Yueyang Maternal and Child Health-Care Hospital), Yueyang, China.
  • Department of Basic Medicine, Changsha Vocational College of Medicine and Health, Changsha, Hunan, China.
  • Joint Laboratory of Translational Medicine in People's Hospital of Shaodong & Hunan Mingshun Pharmaceutical Co., Ltd, Shaodong, China.

ORCID-Profile: Zhongcheng Mo

Förderung

  • Foundation of Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health
  • Special Fund of the Central Government Guiding Local Scientific and Technological Development by Guangxi Science and Technology Department
  • Horizontal Cooperation project with Hunan Mingshun Pharmaceutical Co., Ltd
  • Innovation Project of Guangxi Graduate Education

Zitieren

APA

Zheng, B., Che, X., Chen, Z., Cheng, D., Huang, C., Zeng, Z., & Mo, Z. (2025). Polygonatum Odoratum (Mill.) Druce Alleviates Lipopolysaccharide‐Induced Inflammation and Improves the Ovarian Function in Polycystic Ovary Syndrome Rats. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70116

Vancouver

Zheng B, Che X, Chen Z, Cheng D, Huang C, Zeng Z, et al. Polygonatum Odoratum (Mill.) Druce Alleviates Lipopolysaccharide‐Induced Inflammation and Improves the Ovarian Function in Polycystic Ovary Syndrome Rats. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70116

BibTeX
@article{Zheng2025,
  author = {Zheng, Biao and Che, Xuan and Chen, Zhuo and Cheng, Di and Huang, Congbing and Zeng, Zhaoming and Mo, Zhongcheng},
  title = {Polygonatum Odoratum (Mill.) Druce Alleviates Lipopolysaccharide‐Induced Inflammation and Improves the Ovarian Function in Polycystic Ovary Syndrome Rats},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  doi = {10.1111/aji.70116}
}
Kostenlos starten →